PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'IV-th Department, Hospital for Infectious Diseases, Warsaw, Poland.\', \'Department of Adults\' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland. jdkowalska@gmail.com.\', \'Intensive Care Unit, Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.\', \'Department of Diagnostic Imaging, Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.\', \'Molecular Diagnostics Laboratory, Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.\', \'Central Analytical Laboratory, Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.\', \'Department of Adults\' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s40001-020-00438-x
?:hasPublicationType
?:journal
  • European journal of medical research
is ?:pmid of
?:pmid
?:pmid
  • 32854774
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.55
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • How to follow-up a patient who received tocilizumab in severe COVID-19: a case report.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all